LM
Lara Meisner (Chief Legal Officer) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $1.0M of BCAX (79,146 sh across 2 lots, as filed), executed Mar 14 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Sep 29 2025
Filed Oct 1 2025
Median ADV $19.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 24 months
Most traded names
BCAXRecent filings
BCAXSALE
Bicara Therapeutics Inc.
View filing →
$499K33,807 sh × $14.75
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $182K
15,829 sh × $11.49
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $165K
15,829 sh × $10.43
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $1.0M
79,146 sh across 2 lots
Exec Mar 14 2025
Filed Mar 18 2025 · 5:30 PM ET